Myofibroma/myofibromatosis: MDCT and MR imaging findings in 24 patients with radiological-pathological correlation

Kun-ming Yi, Kang Chen, Qiang Ma, Lu Wang, Ran Li, Yi WangBmc Medical Imaging 2020 · DOI

TL;DR

This study characterizes the imaging features of myofibromas using MDCT and MRI, correlating them with pathological findings in 24 patients. It highlights heterogeneous signal intensity and enhancement as key imaging hallmarks and identifies the absence of a pseudocapsule and younger age as potential risk factors for tumor recurrence.

What Problem Does This Paper Address?

Myofibromas are rare benign fibrous tumors that can occur in infants and adults, presenting a diagnostic challenge due to their varied clinical presentations and locations. While previous studies have reported on individual cases or small series, a comprehensive radiological-pathological correlation for myofibromas, particularly using modern imaging techniques like MDCT and MRI, has been lacking. This paper aims to fill this gap by detailing the imaging characteristics of myofibromas and correlating them with their histopathological features, thereby improving diagnostic accuracy and understanding of recurrence risk factors.

Methods

The study retrospectively reviewed radiological findings from 24 patients with 29 myofibromas. Imaging data from multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) were analyzed. Key imaging features assessed included density, signal intensity, enhancement patterns, and the presence of hypointense areas and pseudocapsules. These findings were then correlated with pathological examination of tumor specimens. Statistical analysis was performed to compare characteristics between recurrent and non-recurrent groups, including age, tumor diameter, and the presence of a pseudocapsule.

Datasets

The study utilized data from 24 patients who underwent preoperative radiological examinations (MDCT and/or MRI) at the authors' institutions between January 2011 and December 2018. No new datasets or benchmarks were introduced.

Key Insights and Ideas

  • Heterogeneity is Key: Myofibromas consistently show heterogeneous density/signal intensity and enhancement on both MDCT and MRI, making this a crucial diagnostic clue.
  • MRI's Subtle Clues: Irregular strip or patchy hypointensities on all MRI sequences, and the presence of a pseudocapsule, are significant findings that correlate with pathological features (collagen fibers and fibrosis) and can aid in diagnosis.
  • Recurrence Predictors: The absence of a pseudocapsule on MRI and a younger patient age appear to be associated with a higher risk of tumor recurrence, suggesting these factors could inform clinical management and follow-up strategies.
  • MDCT Enhancement: Tumors show moderate to marked enhancement on contrast-enhanced MDCT, significantly higher than adjacent skeletal muscle, with progressive enhancement being common.

Key Results

  • MDCT Findings: On unenhanced MDCT, tumors were often heterogeneous (46.7% hypodense, 26.7% hyperdense). Contrast-enhanced MDCT showed moderate (33.3%) to marked (66.7%) heterogeneous enhancement, significantly higher than adjacent muscle (P=0.0001).
  • MRI Findings: On T1WI, tumors were typically heterogeneously slightly hyperintense (82.3%). On T2WI and FS T2WI, all tumors were heterogeneously hyperintense. All tumors showed marked enhancement on FS contrast-enhanced T1WI. Hypointensities were common across all MRI sequences (94.1% to 100%), and pseudocapsules were identified in 29.4% of cases.
  • Recurrence Correlation: The age of the recurrent group (15.3 ± 7.0 years) was significantly lower than the non-recurrent group (38.9 ± 14.3 years) (P=0.001). Tumors without a pseudocapsule on MRI were more likely to recur than those with a pseudocapsule (P=0.034).

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: The study's retrospective nature means there were no standardized imaging protocols, and variations in MDCT and MRI equipment and techniques were used.
  • Small Sample Size: The relatively small number of patients (24) and tumors (29) limits the generalizability of the findings.
  • Underestimation of Multifocal Lesions: Due to the lack of detailed clinical information and the absence of whole-body examinations in some cases, the number of multifocal and generalized lesions may have been underestimated.

Future work could involve larger, prospective studies with standardized imaging protocols to further validate these findings and explore the prognostic implications of imaging features in greater detail.

Summary updated

BibTeX
@article{yi2020myofibroma,
  author = {Kun-ming Yi and Kang Chen and Qiang Ma and Lu Wang and Ran Li and Yi Wang},
  title = {{Myofibroma/myofibromatosis: MDCT and MR imaging findings in 24 patients with radiological-pathological correlation}},
  journal = {Bmc Medical Imaging},
  year = {2020},
  doi = {10.1186/s12880-020-00498-9},
}
Figure